In Office Dispensing

In-Office Dispensing: Weight Management

In-Office Dispensing Weight ManagementAiding your patient population to achieve and maintain healthy weight is a key aspect of reaching healthy, positive, patient outcomes. Unhealthy weight can reduce energy levels and lead to a higher risk of developing:

  • Heart disease
  • High blood pressure
  • Type 2 diabetes
  • Gallstones
  • Breathing problems
  • Certain cancers
  • Joint problems

The Role of Physician-Directed Weight Management

In the ongoing battle against obesity, physician-directed weight management practices play a critical role:

  • Tailored programs to help patients manage this disease
  • Wellness counseling for prevention as well as ongoing weight management
  • Products and services to help alleviate the symptoms, jump-start the weight loss process or help manage a patient’s weight on an ongoing basis
  • Complementary services to support the aesthetic challenges of the weight loss process

Northwind Pharmaceuticals supports physician directed weight management clinics by providing:

  1. Medications relevant to the weight management process
  2. Software to manage the dispensing process
  3. Competitive pricing to help clinics maximize revenue
  4. Shipping and support to meet the timing and service requirements of these specialty clinics
  5. Specialty packaging to allow practitioners to tailor their services to each patient

Connect with Northwind Pharmaceuticals

Learn more by talking with a rep or connecting to our website. We’d love to see how you are working toward your goals!

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading